Effect	effect	O	O	O	O
of	of	O	O	O	O
switching	switching	O	O	O	O
carbamazepine	carbamazepine	CHEMICALS	O	OTHERS	I
to	to	O	O	O	O
oxcarbazepine	oxcarbazepine	O	O	OTHERS	I
on	on	O	O	O	O
the	the	O	O	O	O
plasma	plasma	O	O	O	O
levels	levels	O	O	O	O
of	of	O	O	O	O
neuroleptics	neuroleptics	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

A	a	O	O	O	O
case	case	O	O	O	O
report	report	O	O	O	O
.	.	O	O	O	O

Carbamazepine	carbamazepine	CHEMICALS	O	OTHERS	I
was	was	O	O	O	O
switched	switched	O	O	O	O
to	to	O	O	O	O
its	its	O	O	O	O
10-keto	10-keto	O	O	O	O
analogue	analogue	O	O	O	O
oxcarbazepine	oxcarbazepine	O	O	OTHERS	I
among	among	O	O	O	O
six	six	O	O	O	O
difficult-to-treat	difficult-to-treat	O	O	O	O
schizophrenic	schizophrenic	O	DISEASE	OTHERS	I
or	or	O	O	O	O
organic	organic	O	O	OTHERS	I
psychotic	psychotic	O	O	OTHERS	I
patients	patients	O	O	O	O
using	using	O	O	O	O
concomitantly	concomitantly	O	O	O	O
haloperidol	haloperidol	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
chlorpromazine	chlorpromazine	CHEMICALS	O	OTHERS	I
or	or	O	O	O	O
clozapine	clozapine	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

This	this	O	O	O	O
change	change	O	O	O	O
resulted	resulted	O	O	O	O
within	within	O	O	O	O
2	2	O	O	O	O
-	-	O	O	O	O
4	4	O	O	O	O
weeks	weeks	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
50	50	O	O	O	O
-	-	O	O	O	O
200	200	O	O	O	O
%	%	O	O	O	O
increase	increase	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
plasma	plasma	O	O	O	O
levels	levels	O	O	O	O
of	of	O	O	O	O
these	these	O	O	O	O
neuroleptics	neuroleptics	CHEMICALS	O	OTHERS	I
and	and	O	O	O	O
the	the	O	O	O	O
appearance	appearance	O	O	O	O
of	of	O	O	O	O
extrapyramidal	extrapyramidal	O	DISEASE	OTHERS	I
symptoms	symptoms	O	DISEASE	OTHERS	I
.	.	O	O	O	O

None	none	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
patients	patients	O	O	O	O
showed	showed	O	O	O	O
any	any	O	O	O	O
clinical	clinical	O	O	O	O
deteriotation	deteriotation	O	O	O	O
during	during	O	O	O	O
the	the	O	O	O	O
following	following	O	O	O	O
3	3	O	O	O	O
-	-	O	O	O	O
6	6	O	O	O	O
months	months	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
results	results	O	O	O	O
of	of	O	O	O	O
this	this	O	O	O	O
case	case	O	O	O	O
report	report	O	O	O	O
support	support	O	O	O	O
the	the	O	O	O	O
idea	idea	O	O	O	O
that	that	O	O	O	O
in	in	O	O	O	O
contrast	contrast	O	O	OTHERS	I
with	with	O	O	O	O
carbamazepine	carbamazepine	CHEMICALS	O	OTHERS	I
oxcarbazepine	oxcarbazepine	O	O	OTHERS	I
does	does	O	O	O	O
not	not	O	O	O	O
induce	induce	O	O	O	O
the	the	O	O	O	O
hepatic	hepatic	O	O	O	O
microsomal	microsomal	O	O	O	O
enzyme	enzyme	O	O	O	O
systems	systems	O	O	O	O
regulating	regulating	O	O	O	O
the	the	O	O	O	O
inactivation	inactivation	O	O	O	O
of	of	O	O	O	O
antipsychotic	antipsychotic	CHEMICALS	O	OTHERS	I
drugs	drugs	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

